Home › Forums › General
Discussion forum for members to discuss anything to do with oncology pharmacy › DOACs as VTE prophylaxis for immunomodulatory containing regimens › Reply To: DOACs as VTE prophylaxis for immunomodulatory containing regimens
04/06/2021 at 8:58 am
#14486
![](https://www.bopa.org.uk/wp-content/uploads/2024/05/Profile-scaled-e1716558393690-150x150.jpeg)
Participant